Serotype specificity of the neutralizing-antibody response induced by the individual surface proteins of rotavirus in natural infections of young children

Clinical and Diagnostic Laboratory Immunology

Volumn 5, Issue 3, 1998, Pages 328-334

  Menchaca, Griselda ^a   Padilla Noriega, Luis ^b,i   Méndez Toss, Martha ^b   Contrera, Juan F ^a   Puerto, Fernando I ^c   Guiscafré, Hector ^d   Mota, Felipe ^e   Herrera, Ismael ^f   Cedillo, Roberto ^d   Muñoz, Onofre ^d   Ward, Richard ^g   Hoshino, Yasutaka ^h   López, Susana ^b   Arias, Carlos F ^b  

^a UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

^b INSTITUTO DE BIOTECNOLOGÍA   (Mexico)

^c UNIVERSIDAD AUTÓNOMA DE YUCATÁN   (Mexico)

^d INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^e HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

^f UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

^g CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^h NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

ⁱ UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; NEUTRALIZING ANTIBODY;

ANTIBODY RESPONSE; ARTICLE; CHILD; CONTROLLED STUDY; HUMAN; HUMAN ROTAVIRUS; INFANT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SEROCONVERSION; SEROTYPE; VIRUS INFECTION;

EID: 0031804566     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.5.3.328-334.1998     Document Type: Article

References (67)

1. Arias, C. F., M. Lizano, and S. López. 1987. Synthesis in Escherichia coli and immunological characterization of a polypeptide containing the cleavage sites associated with trypsin enhancement of rotavirus SA11 infectivity. J. Gen. Virol. 68:633-642.
2. Arias, C. F., S. López, J. D. Mascarenhas, P. Romero, P. Cano, Y. B. Gabbay, R. B. de Freitas, and A. C. Linhares. 1994. Neutralizing antibody immune response in children with primary and secondary rotavirus infections. Clin. Diagn. Lab. Immunol. 1:89-94.
3. Bernstein, D. I., D. S. Sander, V. E. Smith, G. M. Schiff, and R. L. Ward. 1991. Protection from rotavirus reinfection: 2-year prospective study. J. Infect. Dis. 164:277-283.
4. Bishop, R. F. 1994. Natural history of human rotavirus infections, p. 131-167. In A. Z. Kapikian (ed.). Viral infections of the gastrointestinal tract, 2nd ed. Marcel Dekker, Inc., New York, N.Y.
5. Brussow, H., H. Werchau, L. Lerner, C. Mietens, W. Liedtke, J. Sidoti, and J. Sotek. 1988. Seroconversion patterns to four human rotavirus scrotypes in hospitalized infants with acute rotavirus gastroenteritis. J. Infect. Dis. 158: 588-595.
6. Chen, D. Y., M. K. Estes, and R. F. Ramig. 1992. Specific interactions between rotavirus outer capsid proteins VP4 and VP7 determine expression of a cross-reactive, neutralizing VP4-specific epitope. J. Virol. 66:432-439.
7. Chiba, S., T. Yokoyama, S. Nakata, Y. Morita, T. Urasawa, K. Taniguchi, S. Urasawa, and T. Nakao. 1986. Protective effect of naturally acquired homotypic and heterotypic rotavirus antibodies. Lancet ii:417-421.
8. Clark, H. F., F. E. Borian, and S. A. Plotkin. 1990. Immune protection of infants against rotavirus gastroenteritis by a serotype 1 reassortant of bovine rotavirus WC3. J. Infect. Dis. 161:1099-1104.
9. Clark, H. F., K. T. Dolan, S. P. Horton, J. Palmer, and S. A. Plotkin. 1985. Diverse scrologic response to rotavirus infection of infants in a single epidemic. Pediatr. Infect. Dis. J. 4:626-631.
10. Contreras, J. F., G. E. Menchaca, L. Padilla Noriega, R. S. Tamez, H. B. Greenberg, S. López, and C. F. Arias. 1995. Heterogeneity of VP4 neutralization epitopes among serotype P1A human rotavirus strains. Clin. Diagn. Lab. Immunol. 2:506-508.
11. Coulson, B. S. 1993. Typing of human rotavirus VP4 by an enzyme immunoassay using monoclonal antibodies. J. Clin. Microbiol. 31:1-8.
12. Coulson, B. S., K. Grimwood, I. L. Hudson, G. L. Barnes, and R. F. Bishop. 1992. Role of coproantibody in clinical protection of children during reinfection with rotavirus. J. Clin. Microbiol. 30:1678-1684.
13. Dunn, S. J., R. L. Ward, M. M. McNeal, T. L. Cross, and H. B. Greenberg. 1993. Identification of a new neutralization epitope on VP7 of human serotype 2 rotavirus and evidence fo relectropherotype differences caused by single nucleotide substitutions. Virology 197:397-404.
14. Estes, M. K. 1996. Rotaviruses and their replication, p. 1625-1655. In B. N. Fields, D. N. Knipe, P. M. Howley, R. M. Chanock, J. L. Melnick, T. P. Monath, B. Roizman, and S. E. Straus (ed.), Virology, vol. 2. Raven Press, New York, N.Y.
15. Feng, N., J. W. Burns, L. Bracy, and H. B. Greenberg. 1994. Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus. J. Virol. 68:7766-7773.
16. Franco, M. A., and H. B. Greenberg. 1995. Role of B cells and cytotoxic T lymphocytes in clearance of and immunity to rotavirus infection in mice. J. Virol. 69:7800-7806.
17. Gentseh, J. R., P. A. Woods, M. Ramachandran, B. K. Das, J. P. Leite, A. Alfieri, R. Kumar, M. K. Bhan, and R. I. Glass. 1996. Review of G and P typing results from a global collection of rotavirus strains: implications for vaccine development. J. Infect. Dis. 174(Suppl. 1):S30-S36.
18. Gerna, G., A. Sarasini, M. Torsellini, D. Torre, M. Parea, and M. Battaglia. 1990. Group- and type-specific serologic response in infants and children with primary rotavirus infections and gastroenteritis caused by a strain of known serotype. J. Infect. Dis. 161:1105-1111.
19. Gorrell, R. J., and R. F. Bishop. 1997. Production of reassortant viruses containing human rotavirus VP4 and SA11 VP7 for measuring neutralizing antibody following natural infection. Clin. Diagn. Lab. Immunol. 4:509-514.
20. Green, K. Y., and A. Z. Kapikian. 1992. Identification of VP7 epitopes associated with protection against human rotavirus illness or shedding in volunteers. J. Virol. 66:548-553.
21. Green, K. Y., J. F. Sears, K. Taniguchi, K. Midthun, Y. Hoshino, M. Gorziglia, K. Nishikawa, S. Urasawa, A. Z. Kapikian, R. M. Chanock, and J. Flores. 1988. Prediction of human rotavirus serotype by nucleotide sequence analysis of the VP7 protein gene. J. Virol. 62:1819-1823.
22. Green, K. Y., K. Taniguchi, E. R. Mackow, and A. Z. Kapikian. 1990. Homotypic and heterotypic epitope-specific antibody responses in adult and infant rotavirus vaccinees: implications for vaccine development. J. Infect. Dis. 161:667-679.
23. Grimwood, K., J. C. Lund, B. S. Coulson, I. L. Hudson, R. F. Bishop, and G. L. Barnes. 1988. Comparison of serum and mucosal antibody responses following severe acute rotavirus gastroenteritis in young children. J. Clin. Microbiol. 26:732-738.
24. Hjelt, K., P. C. Grauballe. A. Paerregaard, O.H. Nielsen, and P. A. Krasilnikoff. 1987. Protective effect of preexisting rotavirus-specific immunoglobulin A against naturally acquired rotavirus infection in children. J. Med. Virol. 21: 39-47.
25. Hoshino, Y., R. W. Jones, and A. Z. Kapikian. 1997. Serotypic characterization of VP4 of vervet monkey rotavirus (RV) SA11 by neutralization, abstr. W38-11. In Reovirus III: infection and immunity; 16th Annual Meeting of the American Society for Virology, Bozeman, Montana.
26. Hoshino, Y., and A. Z. Kapikian. 1994. Rotavirus antigens. Curr. Top. Microbiol. Immunol. 185:179-227.
27. Hoshino, Y., and A. Z. Kapikian. 1994. Rotavirus vaccine development for the prevention of severe diarrhea in infants and young children. Trends Microbiol. 2:242-249.
28. Institute of Medicine. 1986. New vaccine development: diseases of importance in developing countries, p. D13-1-D13-12. National Academy Press, Washington, D.C.
29. Kapikian, A. Z., and R. M. Chanock. 1996. Rotaviruses, p. 1657-1708. In B. N. Fields, D. N. Knipe, P. M. Howley, R. M. Chanock, J. L. Melnick, T. P. Monath, B. Roizman, and S. E. Straus (ed.), Virology, vol. 2. Raven Press, New York, N.Y.
30. Kirkwood, C. D., R. F. Bishop, and B. S. Coulson. 1996. Human rotavirus VP4 contains strain-specific, scrotype-specific and cross-reactive neutralization sites. Arch. Virol. 141:587-600.
31. Mackow, E. R., R. D. Shaw, S. M. Matsui, P. T. Vo, D. A. Benfield, and H. B. Greenberg. 1988. Characterization of homotypic and heterotypic VP7 neutralization sites of rhesus rotavirus. Virology 165:511-517.
32. Matson, D. O., M. L. O'Ryan, I. Herrera, L. K. Pickering, and M. K. Estes. 1993. Fecal antibody responses to symptomatic and asymptomatic rotavirus infections. J. Infect. Dis. 167:577-583.
33. Matson, D. O., M. L. O'Ryan, L. K. Pickering, S. Chiba, S. Nakata, P. Raj, and M. K. Estes. 1992. Characterization of serum antibody responses to natural rotavirus infections in children by VP7-specific epitope-blocking assays. J. Clin. Microbiol. 30:1056-1061.
34. Matsui, S. M., E. R. Mackow, and H. B. Greenberg. 1989. Molecular determinant of rotavirus neutralization and protection. Adv. Virus Res. 36:181-214.
35. McNeal, M. M., K. S. Barone, M. N. Rae, and R. L. Ward. 1995. Effector functions of antibody and CD8+ cells in resolution of rotavirus infection and protection against reinfection in mice. Virology 214:387-397.
36. McNeal, M. M., R. L. Broome, and R. L. Ward. 1994. Active immunity against rotavirus infection in mice is correlated with viral replication and titers of serum rotavirus IgA following vaccination. Virology 204:642-650.
37. McNeal, M. M., M. N. Rae, and R. L. Ward. 1997. Evidence that resolution of rotavirus infection in mice is due to both CD4 and CD8 cell-dependent activities. J. Virol. 71:8735-8742.
38. Midthun, K., H. B. Greenberg, Y. Hoshino, A. Z. Kapikian, R. G. Wyatt, and R. M. Chanock. 1985. Reassortant rotaviruses as potential live rotavirus vaccine candidates. J. Virol. 53:949-954.
39. Offit, P. A., R. D. Shaw, and H. B. Greenberg. 1986. Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to surface proteins vp3 and vp7. J. Virol. 58:700-703.
40. Offit, P. A., E. J. Hoffenberg, N. Santos, and V. Gouvea. 1993. Rotavirus-specific humoral and cellular immune response after primary, symptomatic infection. J. Infect. Dis. 167:1436-1440.
41. O'Ryan, M. L., D. O. Matson, M. K. Estes, and L. K. Pickering. 1994. Anti-rotavirus G type-specific and isotype-specific antibodies in children with natural rotavirus infections. J. Infect. Dis. 169:504-511.
42. Padilla-Noriega, L., S. J. Dunn, S. López, H. B. Greenberg, and C. F. Arias. 1995. Identification of two independent neutralization domains on the VP4 trypsin cleavage products VP5* and VP8* of human rotavirus ST3. Virology 206:148-154.
43. Padilla-Noriega, L., C. F. Arias, S. López, F. Puerto, D. R. Snodgrass, K. Taniguchi, and H. Greenberg. 1990. Diversity of rotavirus serolypes in Mexican infants with gastroenteritis. J. Clin. Microbiol. 28:1114-1119.
44. Padilla-Noriega, L., R. Werner-Eckert, E. R. Mackow, M. Gorziglia, G. Larralde, K. Taniguchi, and H. B. Greenberg. 1993. Serologic analysis of human rotavirus serotypes P1A and P2 by using monoclonal antibodies. J. Clin. Microbiol. 31:622-628.
45. Padilla-Noriega, L., et al. Submitted for publication.
46. Pérez, S. I., M. Blanco, M. Vilar, D. García, L. While, R. González, A. Z. Kapikian, and J. Elores. 1990. Clinical studies of a quadrivalent rotavirus vaccine in Venezuelan infants. J. Clin. Microbiol. 28:553-558.
47. Puerto, F. I., L. Padilla-Noriega, A. Zamora-Chávez, A. Briceño, M. Puerto, and C. F. Arias. 1987. Prevalent patterns of serotype-specific seroconversion in Mexican children infected with rotavirus. J. Clin. Microbiol. 25:960-963.
48. Shaw, R. D., K. J. Fong, G. A. Losonsky, M. M. Levine, Y. Maldonado, R. Yolken, J. Flores, A. Z. Kapikian, P. T. Vo, and H. B. Greenberg. 1987. Epitope-specific immune responses to rotavirus vaccination. Gastroenterology 93:941-950.
49. Shaw, R. D., M. D. Stoner, M. K. Estes, and H. B. Greenberg. 1985. Specific enzyme-linked immunoassay for rotavirus serotypes 1 and 3. J. Clin. Microbiol. 22:286-291.
50. Silberstein, I., L. M. Shulman, E. Mendelson, and I. Shif. 1995. Distribution of both rotavirus VP4 genotypes and VP7 serotypes among hospitalized and nonhospitalized Israeli children. J. Clin. Microbiol. 33:1421-1422.
51. Steele, A. D., M. C. van Niekerk, and M. J. Mphahlele. 1995. Geographic distribution of human rotavirus VP4 genotypes and VP7 serotypes in five South African regions. J. Clin. Microbiol. 33:1516-1519.
52. Taniguchi, K., W. L. Maloy, K. Nishikawa, K. Y. Green, Y. Hoshinu, S. Urasawa, A. Z. Kapikian, R. M. Chanock, and M. Gorziglia. 1988. Identification of cross-reactive and scrotype 2-specific neutralization epitopes on VP3 of human rotavirus. J. Virol. 62:2421-2426.
53. Taniguchi, K., Y. Morita, T. Urasawa, and S. Urasawa. 1987. Cross-reactive neutralization epitopes on VP3 of human rotavirus: analysis with monoclonal antibodies and antigcnic variants. J. Virol. 61:1726-1730.
54. Taniguchi, K., S. Urasawa, and T. Urasawa. 1985. Preparation and characterization of neutralizing monoclonal antibodies with different reactivity patterns to human rotaviruses. J. Gen. Virol. 66:1045-1053.
55. Taniguchi, K., T. Urasawa, N. Kobayashi, M. U. Ahmed, N. Adachi, S. Chiba, and S. Urasawa. 1991. Antibody response to serotype-specific and cross-reactive neutralization epitopes on VP4 and VP7 after rotavirus infection or vaccination. J. Clin. Microbiol. 29:483-487.
56. Taniguchi, K., T. Urasawa, Y. Morila, H. B. Greenberg, and S. Urasawa. 1987. Direct serotyping of human rotavirus in stools by an enzyme-linked immunosorbent assay using scrotype 1-, 2-, 3-, and 4-specific monoclonal antibodies to VP7. J. Infect. Dis. 155:1159-1166.
57. Timenetsky, M. D., S. T., N. Santos, and V. Gouvea. 1994. Survey of rotavirus G and P types associated with human gastroenteritis in São Paulo, Brazil, from 1986 to 1992. J. Clin. Microbiol. 32:2622-2624.
58. Ward, R. L. 1996. Mechanisms of protection against rotavirus in humans and mice. J. Infect. Dis. 174(Suppl. 1):S51-S58.
59. Ward, R. L., and D. I. Bernstein. 1994. Protection against rotavirus disease after natural rotavirus infection. U.S. Rotavirus Vaccine Efficacy Group. J. Infect. Dis. 169:900-904.
60. Ward, R. L., J. D. Clemens, D. R. Knowlton, M. K. Rao, L. F. Van, N. Huda, F. Ahmed, G. M. Schiff, and D. A. Sack. 1992. Evidence that protection against rotavirus diarrhea after natural infection is not dependent on serotype-specific neutralizing antibody. J. Infect. Dis. 166:1251-1257.
61. Ward, R. L., D. R. Knowlton, H. B. Greenberg, G. M. Schiff, and D. I. Bernstein. 1990. Serum-neutralizing antibody to VP4 and VP7 proteins in infants following vaccination with WC3 bovine rotavirus. J. Virol. 64:2687-2691.
62. Ward, R. L., D. R. Knowlton, G. M. Schiff, Y. Hoshino, and H. B. Greenberg. 1988. Relative concentrations of serum neutralizing antibody to VP3 and VP7 proteins in adults infected with a human rotavirus. J. Virol. 62:1543-1549.
63. Ward, R. L., M. M. McNeal, J. D. Clemens, D. A. Sack, M. Rao, N. Huda, K. Y. Green, A. Z. Kapikian, B. S. Coulson, R. F. Bishop, H. B. Greenberg, G. Gerna, and G. M. Schiff. 1991. Reactivities of serotyping monoclonal antibodies with culture-adapted human rotaviruses. J. Clin. Microbiol. 29: 449-456.
64. Ward, R. L., M. M. McNeal, D. S. Sander, H. B. Greenberg, and D. I. Bernstein. 1993. Immunodominance of the VP4 neutralization protein of rotavirus in protective natural infections of young children. J. Virol. 67: 464-468.
65. Woods, P. A., J. Gentsch, V. Gouvea, L. Mata, M. Santosham, Z. S. Bai, S. Urasawa, and R. I. Glass. 1992. Distribution of serotypes of human rotavirus in different populations. J. Clin. Microbiol. 30:781-785.
66. Zheng, B. J., S. X. Han, Y. K. Yan, X. R. Liang, G. Z. Ma, Y. Yang, and M. H. Ng. 1988. Development of neutralizing antibodies and group A common antibodies against natural infections with human rotavirus. J. Clin. Microbiol. 26:1506-1512.
67. Zheng, B. J., S. K. Lo, J. S. Tam, M. Lo, C. Y. Yeung, and M. H. Ng. 1989. Prospective study of community-acquired rotavirus infection, J. Clin. Microbiol. 27:2083-2090.